Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1977 1
1979 1
1980 3
1981 1
1982 2
1984 1
1985 1
1986 5
1987 2
1988 4
1989 3
1990 3
1991 5
1992 1
1993 6
1994 12
1995 12
1996 7
1997 11
1998 5
1999 3
2000 4
2001 8
2002 6
2003 5
2004 4
2005 8
2006 7
2007 8
2008 11
2009 31
2010 29
2011 32
2012 22
2013 20
2014 35
2015 31
2016 45
2017 34
2018 56
2019 40
2020 37
2021 22
Text availability
Article attribute
Article type
Publication date

Search Results

501 results
Results by year
Filters applied: . Clear all
Page 1
[Abatacept].
Iwamoto N, Kawakami A. Iwamoto N, et al. Nihon Rinsho. 2016 Jun;74(6):968-73. Nihon Rinsho. 2016. PMID: 27311187 Review. Japanese.
Claudin-3-deficient C57BL/6J mice display intact brain barriers.
Castro Dias M, Coisne C, Lazarevic I, Baden P, Hata M, Iwamoto N, Francisco DMF, Vanlandewijck M, He L, Baier FA, Stroka D, Bruggmann R, Lyck R, Enzmann G, Deutsch U, Betsholtz C, Furuse M, Tsukita S, Engelhardt B. Castro Dias M, et al. Among authors: iwamoto n. Sci Rep. 2019 Jan 18;9(1):203. doi: 10.1038/s41598-018-36731-3. Sci Rep. 2019. PMID: 30659216 Free PMC article.
Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.
Fujita Y, Fukui S, Suzuki T, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Abe K, Kawakami A. Fujita Y, et al. Among authors: iwamoto n. Intern Med. 2018 Dec 1;57(23):3473-3478. doi: 10.2169/internalmedicine.1121-18. Epub 2018 Jul 6. Intern Med. 2018. PMID: 29984753 Free PMC article.
Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A. Endo Y, et al. Among authors: iwamoto n. Medicine (Baltimore). 2018 Apr;97(15):e0436. doi: 10.1097/MD.0000000000010436. Medicine (Baltimore). 2018. PMID: 29642214 Free PMC article.
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study.
Miyagawa J, Odawara M, Takamura T, Iwamoto N, Takita Y, Imaoka T. Miyagawa J, et al. Among authors: iwamoto n. Diabetes Obes Metab. 2015 Oct;17(10):974-83. doi: 10.1111/dom.12534. Epub 2015 Aug 20. Diabetes Obes Metab. 2015. PMID: 26179187 Free PMC article. Clinical Trial.
IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.
Shimizu T, Koga T, Furukawa K, Horai Y, Fujikawa K, Okada A, Okamoto M, Endo Y, Tsuji S, Takatani A, Umeda M, Fukui S, Sumiyoshi R, Kawashiri SY, Iwamoto N, Igawa T, Ichinose K, Tamai M, Sakamoto N, Nakamura H, Origuchi T, Mukae H, Kuwana M, Kawakami A. Shimizu T, et al. Among authors: iwamoto n. J Intern Med. 2021 Feb;289(2):206-220. doi: 10.1111/joim.13154. Epub 2020 Jul 21. J Intern Med. 2021. PMID: 32691471
501 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page